| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,836 |
9,333 |
$5.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,999 |
9,778 |
$1.26M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,532 |
1,442 |
$527K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,225 |
8,992 |
$207K |
| 55180 |
|
53 |
50 |
$202K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,270 |
4,171 |
$187K |
| 80053 |
Comprehensive metabolic panel |
4,742 |
4,177 |
$178K |
| 87400 |
|
4,128 |
2,051 |
$160K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,053 |
1,923 |
$130K |
| 93975 |
|
590 |
533 |
$126K |
| 81001 |
|
5,040 |
4,795 |
$103K |
| 76801 |
|
462 |
410 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
284 |
278 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
476 |
464 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,255 |
1,756 |
$21K |
| 71046 |
Radiologic examination, chest; 2 views |
861 |
838 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
1,126 |
1,074 |
$18K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
198 |
177 |
$18K |
| 84703 |
|
518 |
479 |
$12K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
44 |
43 |
$10K |
| 87807 |
|
306 |
302 |
$10K |
| 84702 |
|
646 |
569 |
$9K |
| 84484 |
|
1,167 |
959 |
$7K |
| 43235 |
|
15 |
15 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
505 |
445 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
159 |
158 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
81 |
74 |
$3K |
| J3490 |
Unclassified drugs |
212 |
129 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
262 |
200 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
92 |
46 |
$3K |
| 83690 |
|
681 |
625 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
304 |
87 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
353 |
343 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
15 |
15 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
65 |
64 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
214 |
206 |
$1K |
| 84450 |
|
156 |
130 |
$1K |
| 59025 |
Fetal non-stress test |
16 |
16 |
$1K |
| 84075 |
|
157 |
131 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
27 |
25 |
$1K |
| 86901 |
|
630 |
600 |
$1K |
| 86900 |
|
631 |
601 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
29 |
$837.17 |
| 85730 |
|
621 |
567 |
$830.67 |
| 82550 |
|
327 |
311 |
$824.81 |
| 82247 |
|
162 |
134 |
$805.18 |
| 86850 |
|
81 |
78 |
$783.29 |
| 85610 |
|
762 |
683 |
$779.25 |
| 87081 |
|
25 |
25 |
$759.31 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$748.76 |
| 84155 |
|
157 |
131 |
$625.57 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
72 |
72 |
$535.64 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
87 |
54 |
$432.02 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
59 |
59 |
$385.43 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12 |
12 |
$364.92 |
| 82040 |
|
164 |
135 |
$320.07 |
| 96376 |
|
43 |
25 |
$245.39 |
| 83880 |
|
13 |
12 |
$242.90 |
| 80047 |
|
167 |
161 |
$203.25 |
| 80076 |
|
42 |
41 |
$179.43 |
| 82947 |
|
543 |
341 |
$161.99 |
| 83735 |
|
87 |
68 |
$159.96 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
122 |
96 |
$158.23 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
704 |
625 |
$150.72 |
| 36000 |
|
12 |
12 |
$141.18 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
691 |
659 |
$127.17 |
| 83605 |
|
13 |
12 |
$108.57 |
| J2704 |
Injection, propofol, 10 mg |
343 |
325 |
$88.19 |
| 85014 |
|
250 |
237 |
$83.26 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
286 |
250 |
$58.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
60 |
57 |
$45.02 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
24 |
12 |
$44.66 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
12 |
$32.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
60 |
50 |
$31.45 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
18 |
12 |
$30.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
14 |
$22.26 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
302 |
293 |
$21.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
80 |
79 |
$21.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14 |
12 |
$14.30 |
| J1644 |
Injection, heparin sodium, per 1000 units |
21 |
14 |
$3.67 |
| G0378 |
Hospital observation service, per hour |
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
27 |
$0.00 |